News
When she was finally diagnosed with hand dermatitis, she was fast-tracked for UVB red light therapy, but this only ...
"Some are in a living hell." Dr Nelson says more are turning to private healthcare to be seen quickly. But some of them face ...
Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight
The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a diverse range of therapeutic alternatives for treatment ...
Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, today announced that Health Canada has approved NDUVRA (tapinarof cream), 1%, the ...
Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, today announced that Health Canada has approved NDUVRA (tapinarof cream), 1%, the ...
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results